Bio-Rad Laboratories with ticker code (BIO) now have 4 analysts covering the stock. The analyst consensus points to a rating of ‘Buy’. The target price ranges between 950 and 880 with a mean TP of 918.75. Now with the previous closing price of 598.43 this is indicating there is a potential upside of 53.5%. The 50 day moving average now sits at 651.84 while the 200 day moving average is 700.15. The company has a market cap of $19,178m. Find out more information at: https://www.bio-rad.com
The potential market cap would be $29,444m based on the market concensus.
Bio-Rad Laboratories develops, manufactures, and markets life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians’ office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories was founded in 1952 and is headquartered in Hercules, California.
